Overview
- Concise overview of the development of lentivectors and gene therapy, integrating historical facts, the development and experimental application of lentivectors
- Ideal introduction and book of reference for researchers, academics and students interested in this field
- Each chapter can be read independently
- Includes the very latest human clinical trials
- Thorough treatise on an emerging subject?
Part of the book series: SpringerBriefs in Biochemistry and Molecular Biology (BRIEFSBIOCHEM)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents(6 chapters)
About this book
Gene therapy was conceived during the early and mid part of the 20th century. At first, it was considered a revolutionary biomedical procedure, which could potentially cure any disease for which the molecular bases were understood. Since then, gene therapy has gone through many stages and has evolved from a nearly unrealistic perspective to a real life application. Clinical efficacy in humans was demonstrated at the beginning of this century after its successful application in small-scale clinical trials to cure severe immunodeficiency in children. However, their successes were overshadowed some time later by the occurrence of vector-related leukaemia in a number of treated children. It is in this context that lentiviral vectors have appeared, with improved efficiency and, possibly, increased biosafety. Very recently, the first clinical trials with lentivectors have been carried out with some success.
This Brief firstly defines gene therapy, and places lentivectors within this fascinating therapeutic strategy. Then follows a comprehensive description of the development of retroviral and lentiviral vectors and how to specifically target distinct cell types and tissues. The authors also discuss the application of lentivector gene therapy for the treatment of cancer and autoimmune diseases, ending with the application of lentivectors in human gene therapy clinical trials.
Authors and Affiliations
-
Rayne Institute, Division of Infection and Immunity, University College, London, United Kingdom
David Escors
-
Medical School, Department of Physiology-Immunology, Free University of Brussels, Jette, Belgium
Karine Breckpot
-
University College London, London, United Kingdom
Frederick Arce, Holly Stephenson
-
, Nuffield Orthopaedic Centre, University of Oxford, Oxford, United Kingdom
Grazyna Kochan
Bibliographic Information
Book Title: Lentiviral Vectors and Gene Therapy
Authors: David Escors, Karine Breckpot, Frederick Arce, Grazyna Kochan, Holly Stephenson
Series Title: SpringerBriefs in Biochemistry and Molecular Biology
DOI: https://doi.org/10.1007/978-3-0348-0402-8
Publisher: Springer Basel
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Author(s) 2012
Softcover ISBN: 978-3-0348-0401-1Published: 23 March 2012
eBook ISBN: 978-3-0348-0402-8Published: 22 March 2012
Series ISSN: 2211-9353
Series E-ISSN: 2211-9361
Edition Number: 1
Number of Pages: IX, 104
Number of Illustrations: 1 b/w illustrations, 9 illustrations in colour
Topics: Gene Therapy, Immunology, Genetic Engineering, Cell Biology, Oncology